Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX-A in advanced gastric/GEJ adenocarcinoma
NCT03283761Phase 2Completed
- Start
- Sep 2017
- Primary completion
- Dec 2022
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma. Started Sep 2017; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT03283761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03283761.